Advancing
innovative therapies.
As a non-profit scientific association, C3I aims to study, develop and promote the use of innovative therapies in immune-mediated inflammatory diseases (IMIDs).
This includes cell, gene and epigenetic therapies, as well as antibody- and peptide-mediated approaches.
- 01
Evaluate innovative therapies
Study the potential of new therapeutic approaches in autoimmune diseases and contribute to knowledge about their use.
- 02
Develop and support research
Promote fundamental, translational and clinical research, including work on preclinical models and human samples. Design and conduct biomedical research and clinical studies, including as a sponsor.
- 03
Provide medical and scientific expertise
Provide national and international expertise on the use of innovative therapies in autoimmune diseases. Contribute to multidisciplinary discussions through consultative opinions, while treating physicians remain responsible for patient-care decisions.
- 04
Train and inform
Contribute to the training of healthcare professionals, the wider professional community and the public on new therapies and autoimmune diseases.
- 05
Bring expertise together and share knowledge
Establish working groups to advance knowledge. Organise and contribute to medical and scientific meetings, and share information through brochures, books and audiovisual content.
These objectives are drawn from Articles 2 and 3 of the C3I statutes.
From scientific missions to the club’s actions.
Our actions and publications